Nirsevimab (Beyfortus), an antibody targeting respiratory syncytial virus (RSV), is indicated for newborns and infants to prevent bronchiolitis. Available since September 2023, its widespread use ...

The 2022–23 “tripledemic” season—in which influenza, SARS-CoV-2, and respiratory syncytial virus (RSV) all surged at the same time—was especially bad for Arizona, says Efrem Lim, an Arizona State ...

Respiratory Syncytial Virus. RSV is a single-stranded RNA virus in the Pneumoviridae family and the Orthopneumovirus genus. It was first isolated in 1955 from chimpanzees with respiratory illness ...

Respiratory syncytial virus (RSV) is a common viral infection that may lead to serious complications in certain groups. Since 2023, vaccines are now available and are highly recommended ...

Loveday said HMPV is in the pneumoviridae family which includes respiratory syncytial virus. What are the symptoms of HMPV? HMPV symptoms include coughing, fever, nasal congestion and shortness of ...

RESPIRATORY SYNCYTIAL VIRUS (RSV) is a pneumovirus frequently associated with respiratory illnesses. 1-3 While RSV has been known to cause serious complications in infants and young children, it ...

Respiratory syncytial virus (RSV) is a common germ that can settle into your lungs and airways. It's the top cause of upper respiratory infection in babies and toddlers, but anyone can get it.

Evaluation of Guillain–Barré syndrome (GBS) following respiratory syncytial virus (RSV) vaccination among adults 65 years and older. Meeting of the Advisory Committee on Immunization Practices (ACIP) ...

Respiratory Syncytial Virus or RSV is a contagious virus that affects the respiratory system. The symptoms may range from mild, cold-like symptoms, but the infection could result in serious ...

The highly contagious respiratory syncytial virus (RSV) typically causes mild illness, but it can lead to severe respiratory complications, particularly for at-risk individuals. Drawing on local ...